ALK-Positive Squamous Cell Carcinoma Dramatically Responded to Alectinib

Anaplastic lymphoma kinase (ALK) rearrangement is usually observed in patients with adenocarcinoma. Herein, we report a case of squamous cell carcinoma (SCC) with ALK rearrangement treated with alectinib. The patient was a 73-year-old woman without a smoking history. She consulted us with nonproduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagawa, Ray, Ohba, Takehiko, Ito, Eisaku, Isogai, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878901/
https://www.ncbi.nlm.nih.gov/pubmed/29744229
http://dx.doi.org/10.1155/2018/4172721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878901/
https://www.ncbi.nlm.nih.gov/pubmed/29744229
http://dx.doi.org/10.1155/2018/4172721

Ejemplares similares